Overview

A Study of Home Administration of Pemetrexed as Maintenance Treatment for Advanced Nonsquamous Non-Small Cell Lung Cancer (NSCLC)

Status:
Completed

Trial end date:
2013-09-01

Target enrollment:

Participant gender:

Summary

The main purpose for this study is to answer the following research questions: - Can pemetrexed be administered safely at the participant's home, using the same treatment procedure as in a hospital setting? - Will the participant be satisfied with home care? - How might this impact the participant's quality of life? - What are the required medical resources needed to give pemetrexed in a home setting?

Phase:

Phase 2

Details

Lead Sponsor:

Eli Lilly and Company

Treatments:

Pemetrexed